更新于 10月13日

医学经理 (MJ000408)

1.9-2.5万
  • 北京朝阳区
  • 3-5年
  • 硕士
  • 全职
  • 招1人

职位描述

药品临床研究内科研究医药制造生物工程
Primary Responsibilities:

1. Develop product clinical development strategy and executive plan
under appropriate departmental supervision.

2. Skilled in organizing and writing materials related to medical
clinical trials of CDE communication meetings, attending face-to-face
meetings and communicating with CDE experts when necessary.

3. Establish good communication relationship with medical experts in
key fields, and close communication about research programs.

4. Draft, review, and QC of clinical documents to ensure compliance of
documentation to GCP, SOPs.

5. Development medical supervision plan and function as a medical
monitor in case of need, to ensure the quality and safety of the project,
including but not limited to the monitoring of SAE and programme deviation.

6. Work closely with CO, RA, BD, PV and other departments, provide
advice, support and assistance according to project needs (select of leading
PI/ Participate in project meetings and protocol discussion).

7. Serve as primary technical contact with client under appropriate
departmental supervision.

8. Provide medical professional guidance to subordinates.


Qualification:


1. Ph.D. in Medical Science, More than 1 years clinical experience in
oncology or chronic disease therapeutic area.

2. Or master degree major in medical science, More than 3 years
clinical experience in oncology or chronic disease therapeutic area.

3. Or bachelor degree in medicine, More than 5 years clinical
experience in oncology or chronic disease therapeutic area.

4. Be familiar with the key points of clinical trials and relevant
policies and regulations.

5. Languages: Excellent written and read English Excellent oral
English are preferred.


职位福利:五险一金、绩效奖金、餐补、补充医疗保险、弹性工作

工作地点

北京朝阳区大望路电影产业园

职位发布者

丛先生/HR

立即沟通
公司Logo昆翎(北京)医药科技发展有限公司
昆翎(ClinChoice)是一家致力于为生物医药和医疗器械客户提供高品质一站式服务的临床阶段CRO,服务包括临床运营、项目管理、生物统计、数据管理、注册事务、医学事务和药物警戒。昆翎已经在中国、美国、欧洲、印度、日本和菲律宾建立了主要的临床交付中心,目前在全球拥有1800多名员工,其临床运营团队覆盖了亚、欧、北美等七个国家和地区。高盛直投部董事总经理、昆翎董事会成员许小鸥先生认为,“随着创新疗法在全球的增长,CRO公司提供高效、可靠的研发服务能力变得尤其重要。昆翎独特的价值主张结合了其对于本地市场的了解、国际药物研发的经验以及高效的团队执行能力。我们坚信公司强劲的管理层团队以及其高效的执行能力,将为昆翎的发展开启新的篇章。
公司主页